Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Neuroradiology

01-01-2005 | Diagnostic Neuroradiology

Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study

Authors: Joachim Klisch, Ralf Kubalek, Kai M. Scheufler, Ute Zirrgiebel, Joachim Drevs, Martin Schumacher

Published in: Neuroradiology | Issue 1/2005

Login to get access

Abstract

Our aim was to correlate concentrations of circulating vascular endothelial growth factor (VEGF) and serum soluble angiopoietin receptor (sTIE-2) before and after endovascular treatment with the grading in human dural arteriovenous fistulas (DAVFs). In ten patients with DAVFs undergoing diagnostic cerebral angiography and endovascular intervention, pre-treatment and post-treatment levels of plasma VEGF and serum TIE-2 were examined in a prospective study design. A total of 32 plasma samples and 19 serum samples was collected from the cubital vein, the arterial sheath before and—if applicable—after intervention. Plasma VEGF and serum Tie-2 levels were measured by standardized ELISA protocols. In eight of ten patients with DAVF increased circulating VEGF levels (elevation of more than mean + 2 SD of published normal values) were found, whereas two patients showed increased sTIE-2 levels. Six of the seven patients treated by endovascular embolization displayed a post-interventional decrease of VEGF values. The serum TIE-2 levels decreased slightly after intervention. Pre-treatment vVEGF levels varied significantly between patients with grades I and II/III fistulas according to the Cognards classification system. Our pilot study suggests that assessment of angiogenesis parameters in patients with DAVFs might correlate with the DAVFs’ grade. To support the hypothesis that a change in angiogenic indicators may serve as indicators for a response to therapy, a larger number of patients should be followed for a longer time period.
Literature
1.
Harrigan MR (2003) Angiogenic factors in the central nervous system. Neurosurgery 53:639–660CrossRef
2.
Lasjaunias P, Chiu M, terBrugge K, Tolia A, Hurth M, Berenstein A (1986) Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg 64:724–730
3.
Kutluk K, Schumacher M, Mironov A (1991) The role of sinus thrombosis in occipital dural arteriovenous malformations—development and spontaneous closure. Neurochirurgia (Stuttg) 34:144–147
4.
Lawton MT, Jacobowitz R, Spetzler RF (1997) Redifined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87:267–274
5.
Dudeck O, van Velthoven V, Schumacher M, Klisch J (2004) De novo development of a complex dural arteriovenous fistula next to a cerebellar developmental venous anomaly after resection of a brainstem cavernoma. Case report and review of the literature. J Neurosurg 100:335–339
6.
Friedman JA, Meyer FB, Nichols DA, Coffey RJ, Hopkins LN, Maher CO, Meissner ID, Pollock BE (2001) Fatal progression of posttraumatic dural arteriovenous fistulas refractory to multimodal therapy. Case report. J Neurosurg 94:831–835
7.
Hamada Y, Goto K, Inoue T, Iwaki T, Matsuno H, Suzuki S, Matsushima T, Fukui M, Miyake E (1997) Histopathologic aspects of dural arteriovenous fistulas in the transverse–sigmoid sinus region in nine patients. Neurosurgery 40:452–456CrossRef
8.
Nishijima M, Takaku A, Endo S, Kuwayama N, Koizumi F, Sato H, Owada K (1992) Etiologic evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations. J Neurosurg 76:600–606
9.
Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, Bien S, Bertalanffy H (2001) Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94:972–977PubMed
10.
Terada T, Tsuura M, Komai N, Higashida RT, Halbach VV, Dowd C, Hieshima GB (1996) The role of angiogenic factor bFGF in the development of AVFs. Acta Neurochir (Wien) 138:877–883
11.
Uranishi R, Nakase H, Sakaki T (1999) Expression of angiogenic growth factors in dural arteriovenous fistula. J Neurosurg 91:781–786
12.
Chin KF, Greenman J, Reusch P, Gardiner E, Marme D, Monson JR (2003) Vascular endothelial growth factor and soluble Tie-2 receptor in colorectal cancer: associations with disease recurrence. Eur J Surg Oncol 29:497–505CrossRef
13.
Scheufler KM, Drevs J, Van Velthoven V, Reusch P, Klisch J, Augustin HG, Zentner J, Marme D (2003) Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. J Cereb Blood Flow Metab 23:99–110CrossRef
14.
Lee JK, Hong YJ, Han CJ, Hwang DY, Hong SI (2000) Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 17:149–152
15.
Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94:395–404
16.
Awad IA, Little JR, Akarawi WP, Ahl J (1990) Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course. J Neurosurg 72:839–850
17.
Klisch J, Huppertz HJ, Spetzger U, Hetzel A, Seeger W, Schumacher M (2003) Transvenous treatment of carotid cavernous and dural arteriovenous malformations: results in 31 patients with review of the literature. Neurosurgery 53:836–856CrossRef
18.
Chaloupka JC, Huddle DC, Aldermann J (1999) Local induction of angiogenesis within the walls of a dural sinus results in the creation of dural arteriovenous fistula. Demonstration by polymeric release implantation model in swine. J Neurosurg 90:194A
19.
Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, Chiras J, Merland JJ (1995) Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology 194:671–680
20.
Slevin M, Krupinski J, Slowik A, Rubio F, Szczudlik A, Gaffney J (2000) Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport 11:2759–2764
21.
Suzuki R, Fukai N, Nagashijma G, Asai JI, Itokawa H, Nagai M, Suzuki T, Fujimoto T (2003) Very early expression of vascular endothelial growth factor in brain oedema tissue associated with brain contusion. Acta Neurochir Suppl 86:277–279
22.
Herman JM, Spetzler RF, Bederson JB, Kurbat JM, Zabramski JM (1995) Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg 83:539–545
23.
Gunsilius E, Petzer AL, Stockhammer G, Kahler CM, Gastl G (2001) Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 32:275–278
24.
Salgado R, Benoy I, Bogers J, Weytjens R, Vermeulen P, Dirix L, Van Marck E (2001) Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study. Angiogenesis 4:37–43CrossRef
25.
Kraiss LW, Geary RL, Mattsson EJ, Vergel S, Au YP, Clowes AW (1996) Acute reductions in blood flow and shear stress induce platelet-derived growth factor-A expression in baboon prosthetic grafts. Circ Res 79:45–53
26.
Caunt M, Huang YQ, Brooks PC, Karpatkin S (2003) Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 1:2097–2102CrossRef
27.
Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN, Ahn BC, Koh GY (2000) Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 86:952–959
28.
Kim I, Kim JH, Moon SO, Kwak HJ, Kim NG, Koh GY (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19:4549–4552CrossRef
29.
Nourhaghighi N, Teichert-Kuliszewska K, Davis J, Stewart DJ, Nag S (2003) Altered expression of angiopoietins during blood–brain barrier breakdown and angiogenesis. Lab Invest 83:1211–1222CrossRef
30.
Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos GD, Suda T (1998) Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol 10:1217–1227CrossRef
31.
Takakura N, Huang XL, Naruse T, Hamaguchi I, Dumont DJ, Yancopoulos GD, Suda T (1998) Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9:677–686CrossRef
32.
Teichert-Kuliszewska K, Maisonpierre PC, Jones N, Campbell AI, Master Z, Bendeck MP, Alitalo K, Dumont DJ, Yancopoulos GD, Stewart DJ (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49:659–670CrossRef
33.
Zirrgiebel U, Drevs J (2003) Surrogate marker in clinical studies with anti-angiogenic drugs. Int J Clin Pharmacol Ther 41:600–602
Metadata
Title
Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study
Authors
Joachim Klisch
Ralf Kubalek
Kai M. Scheufler
Ute Zirrgiebel
Joachim Drevs
Martin Schumacher
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 1/2005
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1310-3